Neuphoria Therapeutics In... (NEUP)
NASDAQ: NEUP
· Real-Time Price · USD
8.20
0.10 (1.23%)
At close: Aug 15, 2025, 2:22 PM
Neuphoria Therapeutics Revenue
Neuphoria Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Neuphoria Therapeutics generated $15M in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
8
Market Cap
15.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|